Capivasertib treatment associated with hypermetabolism of the spleen
Abstract Capivasertib has emerged as a promising treatment for advanced breast and prostate cancer. Here, we report two cases of metastatic breast cancer patients who developed splenic hypermetabolism on [18 F]-FDG PET/CT following treatment with capivasertib. To our knowledge, these are the first d...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer
2025-03-01
|
| Sarja: | EJNMMI Reports |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s41824-024-00231-7 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|